company background image
CGM

Cegedim ENXTPA:CGM Stock Report

Last Price

€24.50

Market Cap

€335.7m

7D

0%

1Y

1.0%

Updated

27 May, 2022

Data

Company Financials +
CGM fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance5/6
Financial Health3/6
Dividends3/6

CGM Stock Overview

Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide.

Cegedim Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cegedim
Historical stock prices
Current Share Price€24.50
52 Week High€29.80
52 Week Low€20.00
Beta1.31
1 Month Change-0.41%
3 Month Change16.39%
1 Year Change1.03%
3 Year Change-5.41%
5 Year Change-18.98%
Change since IPO142.86%

Recent News & Updates

Mar 03
Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholder Returns

CGMFR Healthcare ServicesFR Market
7D0%3.0%3.7%
1Y1.0%-8.3%-3.7%

Return vs Industry: CGM exceeded the French Healthcare Services industry which returned -21.4% over the past year.

Return vs Market: CGM exceeded the French Market which returned -5.9% over the past year.

Price Volatility

Is CGM's price volatile compared to industry and market?
CGM volatility
CGM Average Weekly Movement7.4%
Healthcare Services Industry Average Movement7.5%
Market Average Movement5.9%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market3.4%

Stable Share Price: CGM is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CGM's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19695,494Jean-Claude Labrunehttps://www.cegedim.com

Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals.

Cegedim Fundamentals Summary

How do Cegedim's earnings and revenue compare to its market cap?
CGM fundamental statistics
Market Cap€335.71m
Earnings (TTM)€26.22m
Revenue (TTM)€524.71m

12.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CGM income statement (TTM)
Revenue€524.71m
Cost of Revenue€305.98m
Gross Profit€218.73m
Other Expenses€192.50m
Earnings€26.22m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Sep 20, 2022

Earnings per share (EPS)1.91
Gross Margin41.69%
Net Profit Margin5.00%
Debt/Equity Ratio81.4%

How did CGM perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

26%

Payout Ratio

Does CGM pay a reliable dividends?

See CGM dividend history and benchmarks
When do you need to buy CGM by to receive an upcoming dividend?
Cegedim dividend dates
Ex Dividend DateJun 29 2022
Dividend Pay DateJul 01 2022
Days until Ex dividend31 days
Days until Dividend pay date33 days

Does CGM pay a reliable dividends?

See CGM dividend history and benchmarks

Valuation

Is Cegedim undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: CGM (€24.5) is trading below our estimate of fair value (€59.88)

Significantly Below Fair Value: CGM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CGM is good value based on its Price-To-Earnings Ratio (12.8x) compared to the European Healthcare Services industry average (34.8x).

PE vs Market: CGM is good value based on its Price-To-Earnings Ratio (12.8x) compared to the French market (16.2x).


Price to Earnings Growth Ratio

PEG Ratio: CGM is poor value based on its PEG Ratio (2.2x)


Price to Book Ratio

PB vs Industry: CGM is good value based on its Price-To-Book Ratio (1.4x) compared to the FR Healthcare Services industry average (2.7x).


Future Growth

How is Cegedim forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


5.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CGM's forecast earnings growth (5.7% per year) is above the savings rate (0.3%).

Earnings vs Market: CGM's earnings (5.7% per year) are forecast to grow slower than the French market (11.9% per year).

High Growth Earnings: CGM's earnings are forecast to grow, but not significantly.

Revenue vs Market: CGM's revenue (4% per year) is forecast to grow slower than the French market (5.8% per year).

High Growth Revenue: CGM's revenue (4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CGM's Return on Equity is forecast to be low in 3 years time (10.7%).


Past Performance

How has Cegedim performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


61.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CGM has high quality earnings.

Growing Profit Margin: CGM's current net profit margins (5%) are higher than last year (2.2%).


Past Earnings Growth Analysis

Earnings Trend: CGM has become profitable over the past 5 years, growing earnings by 61.7% per year.

Accelerating Growth: CGM's earnings growth over the past year (142%) exceeds its 5-year average (61.7% per year).

Earnings vs Industry: CGM earnings growth over the past year (142%) exceeded the Healthcare Services industry -3%.


Return on Equity

High ROE: CGM's Return on Equity (11.3%) is considered low.


Financial Health

How is Cegedim's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CGM's short term assets (€232.7M) do not cover its short term liabilities (€263.7M).

Long Term Liabilities: CGM's short term assets (€232.7M) do not cover its long term liabilities (€301.5M).


Debt to Equity History and Analysis

Debt Level: CGM's net debt to equity ratio (71%) is considered high.

Reducing Debt: CGM's debt to equity ratio has reduced from 132.2% to 81.4% over the past 5 years.

Debt Coverage: CGM's debt is well covered by operating cash flow (50.7%).

Interest Coverage: CGM's interest payments on its debt are well covered by EBIT (4.8x coverage).


Balance Sheet


Dividend

What is Cegedim current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.04%

Current Dividend Yield

Upcoming Dividend Payment

TodayMay 28 2022Ex Dividend DateJun 29 2022Dividend Pay DateJul 01 20222 days from Ex DividendBuy in the next 31 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: CGM's dividend (2.04%) is higher than the bottom 25% of dividend payers in the French market (1.72%).

High Dividend: CGM's dividend (2.04%) is low compared to the top 25% of dividend payers in the French market (5.01%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether CGM's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if CGM's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (26.3%), CGM's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (21.9%), CGM's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

16.2yrs

Average management tenure


CEO

Jean-Claude Labrune

53.33yrs

Tenure

€274,000

Compensation

Mr. Jean-Claude Labrune has been the Chief Executive Officer of Cegedim SA since August 18, 1994. Mr. Labrune serves as President of S.A.S. He founded Cegedim SA in 1969 and served as its Managing Director...


CEO Compensation Analysis

Compensation vs Market: Jean-Claude's total compensation ($USD293.55K) is below average for companies of similar size in the French market ($USD479.65K).

Compensation vs Earnings: Jean-Claude's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CGM's management team is seasoned and experienced (16.2 years average tenure).


Board Members

Experienced Board: CGM's board of directors are considered experienced (5.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cegedim SA's employee growth, exchange listings and data sources


Key Information

  • Name: Cegedim SA
  • Ticker: CGM
  • Exchange: ENXTPA
  • Founded: 1969
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: €335.709m
  • Shares outstanding: 13.70m
  • Website: https://www.cegedim.com

Number of Employees


Location

  • Cegedim SA
  • 137 rue d'Aguesseau
  • Boulogne-Billancourt
  • Ile-de-France
  • 92100
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/27 00:00
End of Day Share Price2022/05/27 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.